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The current communication reports in vitro characterization of the optimized hollow
floating microballoons of amoxicillin on the basis of micromeritic properties and in vitro
minimum inhibitory concentration (MIC). Amoxicillin loaded hollow microballoons were
prepared by emulsion solvent diffusion method. The morphological characterization was
done on the basis of scanning electron microscopy (SEM). Fourier Transformed Infrared
Spectroscopy (FTIR) was used to investigate drugepolymer interactions. The correlation
between the in vitro buoyancy of microballoons and their physical properties, e.g. density
and porosity were elucidated. The results of FTIR spectroscopy revealed the absence of any
drugepolymer interactions. The porosity values of more than 69% and diameter to thick-
ness ratio greater than 2.90, proved a high cavity volume within the microballoons in all
size ranges. The spherical shape of microballoons with hollow internal cavity was
confirmed from SEM photomicrographs. The in vitro MIC results showed a sustained drug
effect from the microballoons. In conclusion, it can be said that the developed micro-
balloons can be used for the effective treatment of Helicobacter pylori induced gastric ulcer.
ª 2013 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V. All
rights reserved.1. Introduction Cancer Research, H. pylori is the main etiologic factor in theMarshall andWarren first isolated Helicobacter pylori (H. pylori),
a gram-negative bacterium, in 1982 from the gastric mucus of
patients with chronic gastritis and duodenal ulcer [1]. As per
the World Health Organization and International Agency for(mobile).
asthi).
g Pharmaceutical Univer
sevier
ang Pharmaceutical Univdevelopment of gastric ulcer and gastric carcinoma [2,3]. The
complete eradication ofH. pylori from the deep gastricmucosa
has remained a challenge due to the drawbacks of currently
available conventional dosage forms as these conventional
systems have a short residence time in the stomach. H. pylorisity
ersity. Production and hosting by Elsevier B.V. All rights reserved.
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retained in the stomach for 1 h. The absorption of an antibiotic
into themucus through themucus layer is believed to bemore
effective for H. pylori eradication than absorption through the
blood [4]. Eradication of the H. pylori resulted in ulcer healing
and prevention of peptic ulcer recurrence [5].
Several approaches such as mucoadhesion, swelling, high
density, raft forming, expandable, magnetic, gas generating,
and superporous hydrogels have been investigated to improve
the bioavailability of drugs by increasing the residence time of
dosage form in the gastric region [6]. It has been reported that
the released drug will have the whole surface area of the
stomach and small intestine for absorption and thus the ab-
sorption of the drug can be enhanced [7]. Multiparticulate drug
delivery systems usually show numerous advantages over
monolithic dosage forms such as a higher degree of dispersion
in the gastrointestinal tract leads to the reduced risk of sys-
temic toxicity due to dose dumping and avoid the “all or none”
emptying pattern of single unit systems [8,9]. A major draw-
back of these systems is the requirement of sufficient volume
of gastric fluid and acid within the stomach to enable the
device to float [10e12]. Since, an optimum gastroretentive
floating system is expected to retain in the stomach for suf-
ficient time against all the physiological barriers and finally
metabolized and eliminated from the body. To fulfill all these
requirements, the system should possess physical properties
like being smaller in size, high buoyancy, and drug encapsu-
lation along with the controlled release of drug in the gastric
environment [6]. Amoxicillin, is rapidly absorbed after oral
administration, has a very short half life (w1 h). Thus it pos-
sesses all the characteristic drug properties required to
develop a gastroretentive controlled release system.
We have previously reported optimization studies on gas-
troretentive floating system of amoxicillin using central
composite design and response surface methodology. A
nonlinear quadratic polynomial model was generated for
precise evaluation of the effects of independent variables on
dependent variables using Design Expert v7.1.5 software (Stat-
Ease, Inc., Minneapolis, Minnesota) [13]. The current
communication dealswith the further in vitro characterization
of the optimized formulation based on its micromeritic
properties and in vitro anti H. pylori activity.2. Materials and methods
2.1. Materials
Amoxicillin was a gift fromWin-Medicare (Meerut, India). CAP
and polyvinyl alcohol were purchased from Central Drug
House (New Delhi, India). Eudragit S100 was purchased from
Evonik Degussa (Mumbai, India). All the other reagents and
solvents used were of analytical grade.
2.2. Optimized method for the preparation of
microballoons
Microballoons were prepared by the emulsion solvent diffu-
sionmethod reported by Awasthi et al. [13]. Briefly, amoxicillin
and Eudragit S100 in a ratio of 1:2.5 (200 mg: 500 mg) and CAP(700 mg) were dissolved in a mixture of dichloromethane,
ethanol and isopropyl alcohol (7:6:2) at room temperature
(15ml). This solutionwas introduced to an aqueous solution of
polyvinyl alcohol (0.5% w/v, 200 ml) at 40 C, forming oil in
water type emulsion. The resultant solution was stirred,
employing a mechanical stirrer (LT400A, Yamato, Japan) at
300 rpm. Finally dispersed droplets were solidified in the
aqueous phase via diffusion of the solvent. Dichloromethane,
evaporated from the solidified dropletswas removed by drying
in hot air oven at 40 C overnight, leaving hollow structure
inside the microballoons. After agitating the system for 1 h at
300 rpm, the resulting polymeric particulate systems were
filtered and dried overnight at 40 C in hot air oven to produce
hollow microballoons.
2.3. Characterization of the optimized microballoons
Separation of the optimizedmicroballoons into three different
fractions was carried out using a mechanical sieve shaker.
The British Standard Sieves (BSS) were arranged in ascending
order i.e. from sieve no # 85e170 (180e90 mm), # 170e300
(90e53 mm) and the third fraction was collected from the
bottomof the sieve no 300 and this fraction consist of particles
those were passed through the sieve no 300. The nest of sieves
was shaken on sieve shaker for 15 min. All three different
fractions were collected, weighed and evaluated for their
micromeritic characterization such as bulk density, tapped
density, particle density, Housner’s ratio, percent porosity, D/
T ratio, Carr’s index and angle of repose. The microballoons
were characterized for morphological examination by scan-
ning electron microscopy (SEM). Studies for shape, drug con-
tent, percent buoyancy and drug release from different
fractions were also conducted to ensure reproducibility of
results based on particle size.
2.3.1. Determination of bulk density, tapped density and
particle density
Different fractions of the optimized formulation (1 g) were
taken intoa10mlgraduatedmeasuringcylinder separatelyand
the volume was noted down. The graduated measuring cylin-
derwas tapped50 timesusingUSPbulk density apparatus (ETD
1020, Electrolab, Mumbai, India). The bulk density and tapped
density were determined using the following formula [14]:
Bulk density ¼Weight of the floating balloons
Initial volume
Tapped density ¼Weight of the floating microballoons
Final volume after tapping
Particle density of different fractions was determined by
the liquid displacement method [15] by suspending the
microballoons in a solvent in which the microballoons were
insoluble like distilled water.
2.3.2. Determination of Hausner’s ratio
The density determinations were used to determine the
Hausner’s ratio by following formula:
Hausners ratio ¼ Tapped density
Bulk density
a s i a n j o u rn a l o f p h a rma c e u t i c a l s c i e n c e s 8 ( 2 0 1 3 ) 1 7 4e1 8 01762.3.3. Characterization of hollow structure of microballoons
The porosity (Є) and diameter to thickness ratio (D/T ) of the
microballoons were used as the parameters for characterizing
the hollow structure of microballoons.
3¼ 1 rp
rt
 100
D
T
¼ 2
1 3
100
1=3
where, rp is particle density and rt is true density.
2.3.4. Angle of repose
For the determination of angle of repose, the microballoons
were poured through a funnel, which was fixed at a position
such that its lower tip was at a height of 2 cm above the sur-
face. Themicroballoons were poured till the timewhen the tip
of the microballoons pile surface touched the funnel. The
tan1 of ratio the height of the pile and radius of its base gave
the angle of repose. The angle of repose was determined by
following formula:
tan1 ¼ h
r
2.3.5. Carr’s index
The density determinationswere used to determine the Carr’s
index by following formula:
Carrs index ¼ Tapped density Bulk density
Tapped density
 100
2.3.6. Determination of buoyancy
Fifty milligrams of microballoons were placed in 100 ml
simulated gastric fluid (SGF, pH 1.2) containing 0.02% Tween
20. The mixture was stirred at 100 rpm on a magnetic stirrer.
After 8 h, the floating and settledmicroballoonswere collected
separately, dried at 40 C and weighed. The buoyancy was
determined by the following formula:Buoyancy ð%Þ ¼ Weight of floating microballoons
Weight of floating microballoonsþWeight of settled microballoons 1002.3.7. Determination of drug content
Accurately weighed (10 mg) microballoons were crushed and
dispersed into 25 ml phosphate buffer (pH 7.4) without any
material loss. After 24 h shaking, the solutionwas filtered, and
the filtrate was analyzed for drug content by a UV-spectro-
photometer (UV 3000þ, LabIndia Instruments, Mumbai, India)
at 227 nm after suitable dilution.
2.3.8. Fourier transform infrared (FTIR) spectroscopy
The optimized formulation was subjected to FTIR spectros-
copy and spectra taken by an FTIR spectrophotometer (IR
affinity-1, Shimadzu, Japan). The formulation was mixed with
suitable amount of KBr and converted into pellets by using KBrpress at 15 tons hydraulic pressure. The IR scanning of sam-
ples was done in between 4000 and 400 cm1 and spectrum
observed for any occurrence and disappearance of charac-
teristic drug peak.
2.3.9. Scanning electron microscopy (SEM)
The external and internal morphology of the microballoons
was studied by scanning electron microscopy (SEM) using a
scanning election microscope (EVO-50, ZEISS, United
Kingdom). The microballoons were adhered to an aluminum
stub using a double adhesive tape. The stubs were then coated
with silver under an argon atmosphere using a high-vacuum
evaporator (Polaron SEM coating system). The photomicro-
graphs of coated samples were taken randomly.
2.3.10. In vitro drug release study
The release rate from different fractions of the optimized
formulation was determined using USP type II apparatus.
Dissolution medium (SGF, pH 1.2, 500 ml) containing 0.02%
Tween 20 was filled in the dissolution vessel and stirred at
50 rpm. The temperature was maintained at 37  0.5 C. A
weight of microballoons equivalent to 50 mg of amoxicillin
was placed in the dissolution vessel. Aliquots werewithdrawn
at every 15 min of the first hour and then at every hour till 4 h
followed by 6 and 82 h. Samples were then analyzed by UV-
spectrophotometer (UV 3000þ, LabIndia Instruments, Mum-
bai, India) at 228 nm. All the dissolution runs were conducted
in triplicate. The release behavior of all the three fractionswas
compared with the optimized formulation (reference formu-
lation) [13]. The mechanism of drug release from the micro-
balloons was confirmed by Peppas’ equation. Differences in
in vitro drug release of amoxicillin from different fractions of
the optimized formulation were statistically analyzed by one-
way analysis of variance (ANOVA) with posttest (Tukey’s
multiple comparison test). Statistically significant difference
between in vitro amoxicillin release from different fractions
was defined as p < 0.05 level. Calculations were performed
using GraphPad prism v5 software (GraphPad prism software
Inc, San Diego, CA) [16].2.3.11. Determination of minimum inhibitory concentration
and duration of action
Minimum inhibitory concentration (MIC) of the optimized
formulation was determined using ATCC 43504 culture of H.
pylori. The strain was grown on Mueller-Hinton agar medium
supplemented with 5% Fetal Calf Serum. The test sample was
suspended in distilled water and added to tubes containing
1 ml of Mueller-Hinton broth at 5, 10, 20, 30, 40 and 50 mg/ml
concentrations. Tubes were inoculated with 10 ml H. pylori
suspension prepared in saline and incubated in the micro-
aerophilic environment (CO2 10%, O2 5%, N2 85%) at 37 C for 5
days. The inoculum was prepared to contain 108 CFU/ml by
adjusting the suspension to match the McFarland No 0.5
Table 1e Evaluation parameter of fractioned formulation.
Parameters Fractions
F1 (180e90 mm) F2 (90e53 mm) F3 (Particle
a s i a n j o u rn a l o f p h a rm a c e u t i c a l s c i e n c e s 8 ( 2 0 1 3 ) 1 7 4e1 8 0 177turbidity standard. The growth was observed as turbidity in
the samples (þ) and inhibition of growthwas confirmed by the
transparent appearance of medium (e). The duration of
growth inhibition was also determined for a period of 84 h.passed through
sieve no 300)
Bulk density
(g/cm3)
0.124  0.002 0.134  0.001 0.144  0.002
Tapped
density
(g/cm3)
0.205  0.002 0.169  0.002 0.150  0.001
Particle
density
(g/cm3)
0.063  0.00 0.054  0.005 0.049  0.0002
Hausner’s
ratio
1.650  0.021 1.270  0.021 1.046  0.009
Percent
porosity
69.31  0.346 68.13  2.83 67.55  0.094
D/T ratio 2.95  0.02 2.92  0.12 2.90  0.00
Angle of
repose (q)
33.25  0.42 29.21  0.35 28.21  0.22
Carrs’ index 39.51  1.36 20.71  0.56 14.40  0.24
Percent
buoyancy
88.00  0.27 90.59  0.42 94.72  0.82
Drug content
(mg/10 mg)
0.926  0.05 1.023  0.04 1.054  0.033. Results and discussion
Controlled release system of amoxicillin was designed and
optimized to increase its residence time in the stomach
without contact with gastric mucosa for effective eradication
of H. pylori infection. Novel hollow microballoons were pre-
pared via emulsion solvent diffusion method. The major
advantage of preparation technique includes short processing
time, the lack of exposure of drug to high temperature, due to
which the drug stability increased during the processing and
which ultimately lead to high encapsulation efficiencies of
drug in the prepared system. The results show that the particle
size of microballoons was closely related to the particle den-
sity, porosity and buoyancy as shown in Fig. 1. The satisfactory
in vitro buoyancy may be attributed to the low bulk density
(0.124e0.144) and optimum porosity of the microballoons
(67.55e69.31). Fig. 1 shows that the true density and porosity of
the microballoons increased with an increase in particle size.
On the other hand the buoyancy of the microballoons
decreased with an increase in particle size. This might be due
to the increased porosity of the microballoons. This causes
increased fluid uptake and leads to increased density of
microballoons and thus microballoons sunk to the bottom.
3.1. Determination of bulk density, tapped density and
particle density
The bulk density and tapped density were determined using
USP bulk density apparatus and the results are represented in
Table 1. The bulk density and tapped density of fraction F2 and
F3 were found to be almost similar, indicating both the frac-
tions have similar flow properties. The differences in bulk
density and tapped density was only 0.01 and 0.02 in case of
fraction F2 and F3 indicating that the change volume is very
less even after 50 tapping, which confirms the small particle
size range and reproducibility in drug content, whereas frac-
tion F1 has comparatively a large range of particle size. The0
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Fig. 1 e Relationship betweenparticle size andmicromeritic
properties of the microballoons (mean ± SD, n[ 3).particle densitywasmeasured by liquid displacementmethod
by suspending the microballoons in distilled water. The
observed particle density ranged from 0.063 to 0.049 g/cm3,
which is less than the specific gravity of the gastric fluid
(1.004 g/cm3), substantiating the buoyant properties of the
microballoons. The effect of true density on the buoyancy of
microballoons is represented in Fig. 1. The percent buoyancy
of microballoons was increased from 88 to 94.72% as the
particle size decreased.
3.2. Determination of Hausner’s ratio
Hausner’s ratio is related to inter-particle friction. Hausner’s
ratio is indirect measures of bulk density, size and shape,
surface area, moisture content and cohesiveness of micro-
balloons. A higher Hausner’s ratio and more fine particles
indicate greater cohesion between particles while a low range
of Hausner’s ratio indicates good flowability. The desirable
value of Hausner’s ratio is <1.25 for good flow of materials.
The Hausner’s ratio of three different fractions was deter-
mined and found to be in the range of 1.05e1.65. The fractions
F2 and F3 exhibited good flow property. On the other hand
fraction F1 exhibited poor flow property. The flow properties
can be arranged as F3 > F2 > F1. An increase in Hausner’s ratio
is due to an increase in particle size, and this might be due to
increased void space between the particles.
3.3. Characterization of hollow structure of
microballoons
The microballoons were characterized by a cavity enclosed
within a hard polymer shell due to the evaporation of
dichloromethane. Diameter thickness ratio (D/T ) is the sig-
nificant parameter for defining the thickness of the wall of
microballoons. Diameter to thickness ratio and percentage
Fig. 2 e FTIR spectra of amoxicillin, Eudragit S100, cellulose
acetate phthalate, physical mixture and formulated
microballoons.
a s i a n j o u rn a l o f p h a rma c e u t i c a l s c i e n c e s 8 ( 2 0 1 3 ) 1 7 4e1 8 0178porosity decreased as the size range decreased and this could
be interpreted as a decrease in the size range resulted in an
increase in thickness of the wall and hence the rigidity which
consequently effected percentage buoyancy at the end of 8 h.
This might be the reason for the increase in buoyancy of
microballoons of smaller size range. The porosity values of
more than 69% and D/T ratio greater than 2.90, proves a high
cavity volumewithin themicroballoons in all size ranges. Fig. 1
shows the relationship between percent porosity and percent
buoyancy with respect to particle size of the microballoons.
The percent porosity decreased and percent buoyancy
increased as the particle size of the microballoons decreased.
3.4. Angle of repose
It is well known that particle size and shape influences flow-
ability. The fine particles (<100 mm) tend to be more cohesive
and therefore less free-flowing, whereas larger denser parti-
cles tend to be free-flowing. The rougher and more irregular
the surface of the particles, the higher will be the angle of
repose. In the present study, the angle of repose increased
from 28.21  0.22 to 33.25  0.42 as the particle size
increased, indicating the decrease in flowability of micro-
balloons. This also supported by the results of Hausner’s ratio
study. Characterizing the flowproperty, angle of repose values
of all microballoons did not exceed 35 and the microballoons
were accepted as free-flowing.
3.5. Carr’s index
A high Carr’s index is indicative of the tendency to form
bridges between the particles. Smaller the Carr’s index, better
will be the flow properties, for example, a value of 5e15 in-
dicates excellent, 12e18 good, 19e21 fair and 22e35 poor flow,
36e40 very poor and >40 extremely poor. The results show
that the fraction F2 and F3 had good and excellent flow prop-
erty, respectively, which is also supported by Hausner’s ratio.
On the other hand fraction F1 exhibited poor flow property.
3.6. Determination of buoyancy
The buoyancy testwas carried out to investigate thefloatability
of the prepared microballoons as it is an important factor
responsible for sustained drug delivery for the gastric region.
The floating ability varied according to the fraction tested. The
buoyancy of microballoons, till the end of 8 h in SGF (pH 1.2)
containing 0.02%w/vTween 20, was found to be 88.00%, 90.00%
and 94.72%, respectively, when the average particle size was
1180e425 mm, 425e180 mm and 180e90 mm. In fraction F3,
Eudragit S100 presented in lowest amount as compared to F2
and F3, resulting higher value of percentage buoyancy for frac-
tionF3. The lowbuoyancyof fractionF1mightbedue to the large
particle size, high particle density and more D/T ratio which
leads to easy penetration ofmedia. The percentage buoyancy is
a factor of polymer concentration in the wall of microballoons.
3.7. Determination of drug content
The drug content increased as the size range of the micro-
balloons decreased. It was found that fraction F1 had thelowest amount of drug as compared with fraction F2 and F3.
This might be due to the diffusion of drug in the aqueous
medium, as a result of increased permeability of the wall of
microballoons in fraction F1. These results again confirmed
the effect of Eudragit S100 on the drug content.
3.8. Fourier transform infrared (FTIR) spectroscopy
FTIR spectroscopy studies were carried out to ascertain that
the processing condition has not led to any interaction be-
tween the drug and the polymer in the formulation. The
formulation was subjected to FTIR spectroscopy to find out
any possible interaction due to the process condition. The
FTIR spectrum of drug, polymers, physical mixture and
formulation are shown in Fig. 2. No sign of any loss or gen-
eration of any characteristic peak in the FTIR spectrum of
physical mixture or formulation was observed; on a compar-
ison with the FTIR spectrum of pure amoxicillin. This
Fig. 3 e Scanning electron micrographs of floating microballoons showing general appearance (A) and internal hollow
structure (B). Scales are given on individual micrograph.
a s i a n j o u rn a l o f p h a rm a c e u t i c a l s c i e n c e s 8 ( 2 0 1 3 ) 1 7 4e1 8 0 179suggested that all the process conditions were relevant to the
formation of microballoons and which in turns showing the
absence of any kind of interaction in between the process
condition, drug and excipients.3.9. Scanning electron microscopy (SEM)
From the SEM micrographs it is apparent that the amoxicillin
loaded microballoons were predominately spherical in
appearance. The surface was observed to be smooth, dense
and less porous, whereas the internal core was highly porous
and irregular with numerous depressions that are expression
of evaporation of water, ethanol and dichloromethane (Fig. 3).
The smooth outer surface and highly porous internal core was
mainly influenced by the diffusion of ethanol and evaporation
of dichloromethane from the polymer matrix. The evapora-
tion of dichloromethane appeared to be related to cavity for-
mation in microballoons. The less porous outer surface and
highly porous internal surface supported controlled release of
drug from the microballoons and good buoyancy.0
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Fig. 4 e Drug release profiles of fractions F1, F2, F3 and
reference formulation in simulated gastric fluid (pH 1.2) at
37 C (mean ± SD, n [ 3).3.10. In vitro drug release
In vitro drug release studies were carried out for all the three
fractions (F1, F2 and F3) using USP type II apparatus. Fig. 4
shows the drug release profiles of fraction F1, F2 and F3. Both
the polymers (Eudragit S100 and cellulose acetate phthalate)
in combination showed excellent control on the release of
drug from themicroballoons in simulated gastric fluid (pH 1.2)
due to their enteric nature. The mechanism of drug release
from the microballoons was confirmed by Peppas’ equation.
According to the logarithmic form of Peppas’ equation, the
rate of drug release can be expressed as:
log Q ¼ log K þ n log t
where Q is the amount of drug released, t is the time, K is a
kinetic constant that incorporates the structural and geo-
metric characteristics of the release device and n is the slope
of the linear plot. If the value of n is less than or equal to 0.5,
themechanism of drug release is diffusionwithout swelling. If
the value is greater than 0.5 and less than 1, the release isthrough diffusion with swelling and if it is above 1, the release
mechanism is anomalous diffusion, not confirming to Fick’s
laws (non-Fickian) [13,16]. In this study, the Peppas’ plots (log
percent release against log time) were straight line for all the
fractions, with correlation coefficients ranging between 0.987
and 0.992 and slope “n” values less than 0.5 (Table 2). This
confirms that the release mechanism of drug from the pre-
pared microballoons was Fickian diffusion without swelling.
On application of one-way analysis of variance (ANOVA) fol-
lowed by Tukey’s multiple comparison test, there was no
significant difference observed between the in vitro drug
release profiles of amoxicillin from the different fractions (F1,
F2 and F3) at 95% confidence interval ( p < 0.05) as the calcu-
lated F value (0.006213) was found smaller than the tabulated
value (2.21). The results of Tukey’s multiple comparison test
showed that there was no significant difference between the
in vitro drug release profile of amoxicillin from the different
fractions (F1, F2 and F3) at 95% confidence interval ( p < 0.05)
because the calculated q values are smaller than the tabulated
values.
Table 2e Results of Peppas’ equation kinetics parameters
for drug release from different fractions of the optimized
formulation.
Fraction
code
Correlation
coefficient (r)
Slope (n) K value
F1 0.986 0.342 0.875
F2 0.987 0.429 0.676
F3 0.992 0.420 0.711
Table 3e Results of in vitro antiH. pylori study usingATCC
43504 culture.
Minimum inhibitory
concentration
(MIC)
Concentrations
(mg/ml)
UT 5 10 20 30 40 50
Test 1: amoxicillin þ þ e e e e e
Test 2: optimized
formulation
þ þ þ e e e e
Duration of action
(20 mg/ml)
Time (h) 12 24 36 48 60 72 84
Test 1: amoxicillin e e e þ þ þ þ
Test 2: optimized
formulation
e e e e e e þ
UT untreated; (þ) Turbidity of themedium, indicating growth of the
microorganism; (e) Transparent appearance of the medium, indi-
cating inhibition of growth.
a s i a n j o u rn a l o f p h a rma c e u t i c a l s c i e n c e s 8 ( 2 0 1 3 ) 1 7 4e1 8 01803.11. Minimum inhibitory concentration (MIC) and
duration of action
The results of in vitro H. pylori growth inhibition study
indicate that the optimized formulation exhibited lower in-
hibition (MIC 20 mg/ml) than the free drug (MIC 10 mg/ml) but
for a long period of time (72 h). The results of MIC and duration
of action of developed optimized formulation are shown in
Table 3.4. Conclusion
In the present work, hollow floating microballoons of
amoxicillin were formulated. The optimized formulation was
further characterized to ascertain the properties of micro-
balloons to be used as a gastroretentive drug delivery system
for local availability of drug. In consideration of Carr’s index
and Hausner’s ratio, microballoons of fraction F3 were
appeared predominant in flowability. The developed micro-
balloons exhibited excellent properties to be used as a gas-
troretentive dosage form. Also, in vitro anti H. pylori study
confirmed that the developed system had good antimicrobial
activity for a prolonged time period. Thus, from the results it
can be concluded that the amoxicillin loaded hollow micro-
balloons appears to have promising potential for localizedrug release for effective treatment of H. pylori induced
peptic ulcer.r e f e r e n c e s
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